The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma
Open accessAbstract
Glaucoma is an optic neuropathy with cupping of the optic disk, degeneration of retinal ganglion cells, and characteristic visual field loss. Because elevated intraocular pressure (IOP) is a major risk factor for progression of glaucoma, treatment has been based on lowering IOP. We previously demonstrated inducible nitric-oxide synthase (NOS-2) in the optic nerve heads from human glaucomatous eyes and from rat eyes with chronic, moderately elevated IOP. Using this rat model of unilateral glaucoma, we treated a group of animals for 6 months with aminoguanidine, a relatively specific inhibitor of NOS-2, and compared them with an untreated group. At 6 months, untreated animals had pallor and cupping of the optic disks in the eyes with elevated IOP. Eyes of aminoguanidine-treated animals with similar elevations of IOP appeared normal. We quantitated retinal ganglion cell loss by retrograde labeling with Fluoro-Gold. When compared with their contralateral control eyes with normal IOP, eyes with elevated IOP in the untreated group lost 36% of their retinal ganglion cells; the eyes with similarly elevated IOP in the aminoguanidine-treated group lost less than 10% of their retinal ganglion cells. Pharmacological neuroprotection by inhibition of NOS-2 may prove useful for the treatment of patients with glaucoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Advanced protein glycosylation in diabetes and aging
Brownlee, M. D. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.223 · Cited by 1,312
Optic Nerve Damage in Human Glaucoma: II. The Site of Injury and Susceptibility to Damage
Quigley, H. A. (1981) · Archives of Ophthalmology · doi:10.1001/archopht.1981.03930010635009 · Cited by 1,244
Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-Linking
Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P., & Cerami, A. (1986) · Science · doi:10.1126/science.3487117 · Cited by 1,146
Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis.
Quigley, H. A., Nickells, R. W., Kerrigan, L. A., Pease, M. E., Thibault, D., & Zack, D. J. (1995) · PubMed · Cited by 935
Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction
Corbett, J. A., Tilton, R. G., Chang, K., Hasan, K. S., Ido, Y., Wang, J. L., Sweetland, M. A., Lancaster, J. R., Williamson, J. R., & McDaniel, M. L. (1992) · Diabetes · doi:10.2337/diab.41.4.552 · Cited by 628
Di Polo, A., Aigner, L. J., Dunn, R. J., Bray, G. M., & Aguayo, A. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3978 · Cited by 430
Nitric Oxide Synthase in the Human Glaucomatous Optic Nerve Head
Neufeld, A. H. (1997) · Archives of Ophthalmology · doi:10.1001/archopht.1997.01100150499009 · Cited by 342
Self-citationChronic ocular hypertension following episcleral venous occlusion in rats
Shareef, S. R., Garcia-Valenzuela, E., Salierno, A., Walsh, J., & Sharma, S. C. (1995) · Experimental Eye Research · doi:10.1016/s0014-4835(05)80131-9 · Cited by 299
Sellés-Navarro, I., Villegas‐Pérez, M. P., Salvador‐Silva, M., Ruiz-Gómez, J. M., & Vidal‐Sanz, M. (1996) · PubMed · Cited by 272
Medical Management of Glaucoma
Alward, W. L. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810293391808 · Cited by 252
Elevation of Intraocular Glutamate Levels in Rats With Partial Lesion of the Optic Nerve
Yoles, E. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.7.906 · Cited by 173
Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis
Brenner, T., Brocke, S., Szafer, F., Sobel, R. A., Parkinson, J. F., Perez, D. H., & Steinman, L. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.6.2940 · Cited by 159
Nitric Oxide in Neuronal Degeneration
Dawson, V. L., & Dawson, T. M. (1996) · Experimental Biology and Medicine · doi:10.3181/00379727-211-43950e · Cited by 136
Soulis, T., Cooper, M. E., Sastra, S. A., Thallas, V., Panagiotopoulos, S., Bjerrum, O. J., & Jerums, G. (1997) · Diabetologia · doi:10.1007/s001250050799 · Cited by 101
Shareef, S., Sawada, A., & Neufeld, A. H. (1999) · PubMed · Cited by 98
Self-citationHyperthermia and hypoxia increase tolerance of retinal ganglion cells to anoxia and excitotoxicity.
Caprioli, J., Kitano, S., & Morgan, J. E. (1996) · PubMed · Cited by 91
Bryk, R., & Wolff, D. J. (1998) · Biochemistry · doi:10.1021/bi972065t · Cited by 77
Effects of nitric oxide synthase inhibitors on bone formation in rats
Turner, C. H., Owan, I., Jacob, D., McClintock, R., & Peacock, M. (1997) · Bone · doi:10.1016/s8756-3282(97)00202-0 · Cited by 75
Inhibition of NMDA receptors and nitric oxide synthase reduces ischemic injury of the retina
Adachi, K., Fujita, Y., Morizane, C., Akaike, A., Ueda, M., Satoh, M., Masai, H., Kashii, S., & Honda, Y. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00317-3 · Cited by 69
Cited by
The impact of ocular blood flow in glaucoma
Flammer, J., Orgül, S., Costa, V. P., Orzalesi, N., Krieglstein, G. K., Serra, L. M., Renard, J.-P., & Stefánsson, E. (2002) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(02)00008-3 · Cited by 1,709
Retinal ischemia: mechanisms of damage and potential therapeutic strategies
Osborne, N. N., Casson, R. J., Wood, J. P. M., Chidlow, G., Graham, M., & Melena, J. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2003.12.001 · Cited by 1,056
Mitochondrial dysfunction as a cause of optic neuropathies
Carelli, V., Ross-Cisneros, F. N., & Sadun, A. A. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2003.10.003 · Cited by 839
Oxidative stress in glaucomatous neurodegeneration: Mechanisms and consequences
Tezel, G. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.07.003 · Cited by 723
The optic nerve head in glaucoma: role of astrocytes in tissue remodeling
Hernandez, M. R. (2000) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(99)00017-8 · Cited by 570
Metadata
- Authors
- Neufeld, A. H., Sawada, A., & Becker, B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-08-17
- Volume
- 96
- Issue
- 17
- Pages
- 9944-9948
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2122477596
- Cited by
- 374
- References
- 19
- FWCI
- 23.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.